Apellis Pharmaceuticals, Inc. (APLS)
NASDAQ: APLS · Real-Time Price · USD
19.10
+0.59 (3.19%)
At close: Jun 5, 2025, 4:00 PM
19.34
+0.24 (1.26%)
After-hours: Jun 5, 2025, 7:00 PM EDT

Apellis Pharmaceuticals Market Cap

Apellis Pharmaceuticals has a market cap or net worth of $2.40 billion as of June 5, 2025. Its market cap has decreased by -52.12% in one year.

Market Cap
2.40B
Enterprise Value
2.51B
1-Year Change
-52.12%
Ranking
Category
Stock Price
$19.10

Market Cap Chart

Since November 9, 2017, Apellis Pharmaceuticals's market cap has increased from $691.07M to $2.40B, an increase of 247.36%. That is a compound annual growth rate of 17.87%.

History

DateMarket Cap% Change
Jun 4, 20252.33B-41.39%
Dec 31, 20243.97B-44.04%
Dec 29, 20237.09B24.06%
Dec 30, 20225.72B24.22%
Dec 31, 20214.60B6.25%
Dec 31, 20204.33B121.45%
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 686.22B
Johnson & Johnson 369.02B
AbbVie 332.08B
Novo Nordisk 324.15B
UnitedHealth Group 270.51B
Abbott Laboratories 232.29B
Novartis AG 229.87B
AstraZeneca 226.47B
Market Cap Rankings